Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Ajooni Biotech

₹7 0.1 | 1.9%

Market Cap ₹121 Cr.

Stock P/E 55.9

P/B 1.4

Current Price ₹7

Book Value ₹ 5

Face Value 2

52W High ₹10.3

Dividend Yield 0%

52W Low ₹ 4.3

Ajooni Biotech Research see more...

Overview Inc. Year: 2010Industry: Animal Feed

Ajooni Biotech Ltd is an India-based organisation. The Company is engaged in manufacturing, producing, processing and supplying of farm animals feed, and vitamins supplements. The Company's products portfolio consists of Autus Animal Healthcare and Patanjali. Autus animal healthcare, which incorporates farm animals feed and feeds supplements. Patanjali, which gives Patanjali Silver Ration, Patanjali Gold Chips, Patanjali Gold Plus Chips, Patanjali Diamond Chips, Patanjali Energy Rich Supplements, And Patanjali Minvit.

Read More..

Ajooni Biotech Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Peer Comparison

Ajooni Biotech Quarterly Results

#(Fig in Cr.) Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 12 10 11 41 21 19 20 20 26 26
Other Income 0 0 0 0 0 0 2 0 0 0
Total Income 12 10 11 42 21 20 22 20 26 26
Total Expenditure 12 10 10 40 20 19 21 18 25 25
Operating Profit 1 1 0 1 1 1 1 2 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 1 0 1 1 1 1 1
Provision for Tax 0 0 -0 0 -0 0 0 1 0 0
Profit After Tax 0 0 0 1 0 0 0 1 0 1
Adjustments -0 -0 0 0 -0 0 0 -0 0 0
Profit After Adjustments 0 0 0 1 0 0 0 1 0 1
Adjusted Earnings Per Share 0.1 0 0 0.1 0 0 0.1 0.1 0 0

Ajooni Biotech Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 1 7 13 29 42 40 40 51 74 74 80 92
Other Income 0 0 0 0 0 0 0 0 0 0 2 2
Total Income 1 7 13 29 43 40 40 51 74 75 82 94
Total Expenditure 1 7 13 28 41 39 39 49 71 72 78 89
Operating Profit 0 0 0 1 1 1 1 2 3 3 4 5
Interest 0 0 0 0 0 0 0 1 1 0 1 0
Depreciation 0 0 0 0 0 0 0 1 1 1 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 0 0 0 1 1 2 3 4
Provision for Tax 0 0 0 0 0 0 0 0 0 0 1 1
Profit After Tax 0 0 0 0 0 0 0 0 1 1 2 2
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 0 0 0 0 1 1 2 2
Adjusted Earnings Per Share 0 0.2 0.3 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.2

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 8% 16% 15% 55%
Operating Profit CAGR 33% 26% 32% 0%
PAT CAGR 100% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 17% -12% 42% NA%
ROE Average 5% 5% 4% 10%
ROCE Average 8% 8% 6% 12%

Ajooni Biotech Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 0 0 1 1 11 12 16 16 16 42 43
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 1 0 4 1 2 3 2 2
Other Non-Current Liabilities 0 0 -0 3 2 -0 -0 -0 -0 -0 -0
Total Current Liabilities 0 1 2 8 6 2 6 10 10 15 3
Total Liabilities 0 2 2 13 19 18 23 28 29 58 47
Fixed Assets 0 0 0 1 1 1 2 4 6 6 10
Other Non-Current Assets 0 0 0 6 7 5 3 3 1 17 5
Total Current Assets 0 1 2 6 11 12 18 21 22 35 32
Total Assets 0 2 2 13 19 18 23 28 29 58 47

Ajooni Biotech Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 0 0 0 0 0 5 1 0 0 0 0
Cash Flow from Operating Activities -0 0 -1 0 0 -5 -4 1 4 -6 -4
Cash Flow from Investing Activities -0 -0 -0 0 0 1 0 -3 -2 -16 8
Cash Flow from Financing Activities 0 0 1 0 0 -1 3 2 -2 22 -4
Net Cash Inflow / Outflow 0 0 -0 0 0 -5 -1 0 -0 0 0
Closing Cash & Cash Equivalent 0 0 0 0 0 1 0 0 0 0 0

Ajooni Biotech Ratios

# Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) 0.02 0.2 0.27 0.55 0.12 0.12 0.07 0.07 0.21 0.13 0.25
CEPS(Rs) 0.02 0.29 0.47 0.93 0.22 0.25 0.18 0.19 0.43 0.24 0.35
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0.98 1.18 1.45 1.92 3.19 3.43 3.34 3.1 3.27 4.76 4.87
Core EBITDA Margin(%) 2.05 1.83 1.74 2.34 2.19 1.78 3.02 3.23 4.15 3.71 2.79
EBIT Margin(%) 2.12 1.49 1.22 1.84 1.97 1.53 2.02 2.13 2.7 2.76 4.43
Pre Tax Margin(%) 2.02 1.46 1.07 1.36 1.15 1.2 1.2 0.99 1.97 2.12 3.74
PAT Margin (%) 1.35 1.01 0.73 0.97 0.91 1.03 0.87 0.73 1.42 1.51 2.7
Cash Profit Margin (%) 1.37 1.45 1.27 1.64 1.65 2.14 2.1 1.86 2.92 2.86 3.79
ROA(%) 3.04 6.89 4.78 3.61 2.4 2.2 1.69 1.47 3.7 2.58 4.09
ROE(%) 4.28 18.72 20.38 36.98 6.8 3.72 2.54 2.4 6.58 3.87 5.12
ROCE(%) 6.73 27.57 18.62 36.19 10.03 3.84 4.35 5.07 9.09 5.99 7.75
Receivable days 60.44 22.49 27.7 16.1 17.94 35.36 79.67 94.23 67.91 84.26 76.34
Inventory Days 109.08 13.4 10.6 29.6 26.78 32.48 38.09 30.97 27.75 31.55 50.94
Payable days 52.3 36.96 31.05 45.37 29.93 10.48 16.19 31.11 34.78 46.94 30.34
PER(x) 0 0 0 0 37.96 23.11 14.32 63.36 49.93 27.12 21.09
Price/Book(x) 0 0 0 0 1.41 0.81 0.32 1.52 3.2 0.73 1.07
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.25 0.01 0.07 0.03 0.43 0.41 0.28 0.72 0.98 0.53 0.67
EV/Core EBITDA(x) 11.76 0.75 4.07 1.19 15.86 15.57 8.68 22.19 23.34 12.9 12.07
Net Sales Growth(%) 0 1166.04 83.46 115.71 48.51 -6.27 0.79 27.49 45.06 0.61 7.55
EBIT Growth(%) 1310 785.95 50.37 224.98 59.38 -27.43 33.45 34.59 83.88 2.69 72.89
PAT Growth(%) 870 845.45 32.55 185.79 40 6.45 -15.62 7.57 181.14 7.24 92.16
EPS Growth(%) 132.77 845.45 32.55 103.17 -78.26 1.26 -38.2 0.44 180.97 -38.74 92.13
Debt/Equity(x) 0 0 1.5 0.64 0.45 0.41 0.32 0.44 0.33 0.12 0.05
Current Ratio(x) 2.67 1.19 1.25 0.73 1.87 6.14 3 2.05 2.18 2.28 10.74
Quick Ratio(x) 1.5 0.89 1 0.22 1.56 3.54 2.43 1.53 1.6 1.82 5.63
Interest Cover(x) 20.17 63.06 7.94 3.84 2.41 4.63 2.47 1.86 3.71 4.3 6.38
Total Debt/Mcap(x) 0 0 0 0 0.25 0.39 0.79 0.22 0.08 0.15 0.04

Ajooni Biotech Shareholding Pattern

# Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Promoter 32.41 36.39 36.39 30.29 27.46 26.44 26.44 26.89 26.89 26.89
FII 0.24 0.01 0.01 0 0 0 0 0 0.29 0.18
DII 0 0 0 0 0 0 0 0 0 0
Public 67.36 63.6 63.6 69.71 72.54 73.56 73.56 73.11 72.82 72.92
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 46.94 to 30.34days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 26.89%.
  • Company has a low return on equity of 5% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Ajooni Biotech News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....